The role of coxiella effector proteins in infection and disease - coxiella burnetii is an intracellular pathogen that causes the human disease q-fever
Ended Project Grant Awarded Last action
- Award ID
- R56AI182383
- Recipient
-
Yale Univ UEI FL6GV84CKN57
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $625,276
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Connecticut, USA
Award details come from USAspending.gov.
Description
This project is focused on the novel mechanisms coxiella has evolved to manipulate the host cell. The coxiella DOT/ICM type IVB secretion system is essential for intracellular replication. The goal of this project is to understand how effector proteins delivered into host cells by the DOT/ICM system enable coxiella to replicate in a hydrolytic lysosomal organelle and evade host detection. We have developed genetic tools to identify the important coxiella proteins that are required for host manipulation. This project will leverage these genetic tools in combination with molecular and biochemical approaches to investigate how these effector proteins interfere with host pathogen sensors, promote biogenesis of the unique coxiella-containing vacuole (CCV), and facilitate infection in animals. Knowledge gained from these studies will lead to a greater understanding of pathogen adaptations that enable coxiella to infect mammalian hosts and the immune pathways that are important for controlling intracellular bacterial pathogens. Specific goals include functional analysis of the proteins emca and emcb that are involved in suppression of host immune responses, using newly developed genetic tools to define epistatic interactions between effectors required for CCV biogenesis, and to use bioluminescence imaging to measure virulence defects displayed by coxiella effector mutants.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $62,529 | |
| Original award | $562,747 |
Quick answers
Who received award R56AI182383?
R56AI182383 was awarded to Yale Univ by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 8, 2024.
How much is award R56AI182383 worth?
$625,276 has been obligated on R56AI182383.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award